...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR 2019

Bear,,,, can we assume this is the preamble or basis for the Pfizer + RVX combo trial which we expect to be started this quarter??...

Share
New Message
Please login to post a reply